[1] Wongjarupong N, Negron-Ocasio GM, Chaiteerakij R, et al. Model combiningpre-transplant tumor biomarkers and tumor size shows more utility in predicting hepatocellular carcinoma recurrence and survival than the BALAD models. World J Gastroenterol,2018,24: 1321-1331. [2] 王茹,杨晓莹,王克英,等. 纹理分析对经动脉化学栓塞治疗术后肝癌复发的评价. 中华肝脏病杂志,2017,25: 200-204. [3] 刘兆君,刘伟,崔成华,等. A激酶锚定蛋白12基因甲基化与原发性肝癌复发的关系研究. 中华预防医学杂志,2017,51: 848-852. [4] 丛文铭.肝癌复发转移的分子机制与病理学评估策略. 中华肝脏病杂志,2016,24: 324-326. [5] 张远标,卢毅,吴伟顶,等.术前中性粒细胞/淋巴细胞比值在甲胎蛋白阴性肝细胞肝癌术后复发中的预测价值. 中华普通外科杂志,2016,31: 387-390. [6] 徐晓林,丁建民,高英堂,等.外周血IL-6对早期肝癌微波消融后复发的预测. 介入放射学杂志,2017,26: 232-236. [7] 田璐,吴炯,朱捷等.C5L2表达与肝癌患者预后分析. 复旦学报(医学版),2017,44: 280-287. [8] 王政禄,张鲁洲,滕大洪,等.多结节肝细胞癌克隆起源与肝移植后肝癌复发的相关性研究. 中华器官移植杂志,2016,37: 592-600. [9] 杨景震,王成健,霍英杰,等.3.0T MR 检出和诊断<1.0 cm微小肝癌应用体会. 实用放射学杂志,2014,30: 1415-1418. [10] Mei Wang,CongXin Wei,ZhaoJuan Shi,et al. Study on the diagnosis of small hepatocellular carcinoma caused by hepatitis B cirrhosis via multi-slice spiral CT and MRI. Oncol Lett,2018,15:503-508. [11] Gigin Lin,Kayvan R Keshari,Jae Mo Park.Cancer Metabolism and Tumor Heterogeneity:Imaging Perspectives Using MR Imaging and Spectroscopy. Contrast Media &Molecular Imaging,2017,1-18. [12] Pelin A, Wang J, Bell J, et al. The importance of imaging strategies for pre-clinical and clinical in vivo distribution of oncol viruses. Oncolytic Virother,2018,7: 25-35. [13] 李靖,朱文良,康鑫鑫,等.经肝动脉化疗栓塞联合射频消融治疗原发性肝癌的预后影响因素及预测模型. 中华肿瘤杂志,2017,39: 787-791. [14] 李若坤,曾蒙苏,强金伟,等.MR磁敏感加权成像对肝硬化背景下小肝癌的诊断价值. 中华放射学杂志,2015,49: 520-524. [15] 沈继明,张学琴,梁宏伟,等.DWI、T2WI及MR动态增强扫描成像对不同分化小肝癌定量研究. 中国CT和MRI杂志,2016,14: 75-77. [16] 李惠,王绮,袁建军,等.小肝细胞性肝癌迟发性复发病灶超声造影特征观察. 中华超声影像学杂志,2016,25: 776-779. |